Your Path to Virtualization

The COVID-19 pandemic drove 45% of clinical trial sites to transition patients from in-person to remote visits using virtual trial solutions. Disruptions preventing or limiting site access to patients, monitors, and CRAs are propelling long-lasting changes in the research industry, supported by the adoption of virtualization technologies. The urgency to adapt to evolving requirements for both patients and sites is prompting sponsors to engage in new discussions with their CROs. Trial success relies on driving the pace, flexibility, and adoption of new capabilities. The need for a rapid response is also creating new opportunities for sponsors to fundamentally evolve their technology strategy and leap into the next generation of clinical trials, far beyond COVID-19. This eBook provides eight parameters to help sponsors optimize their path to virtualization across key site- and patient-centric capabilities.

Enter your details to receive the free white paper:

By downloading this Whitepaper, you acknowledge that Global Data Plc may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Global Data Plc may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.